The PREPARE (PREemptive Pharmacogenomic testing for prevention of Adverse drug Reactions) Study has been opened for recruitment! The first patient has been included in Aviano, Italy.
The PREPARE study aims to assess the impact of pharmacogenomic testing on incidence and severity of adverse drug reactions (side-effects). The PREPARE study will recruit patients who receive a first prescription for a drug for which a pharmacogenomic dosing recommendation is available. The study runs in seven European countries (Spain, Greece, Slovenia, Austria, Italy, The United Kingdom, and The Netherlands). Please click here [link: http://upgx.eu/study/] for more information on the PREPARE Study.